Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Infectious Diseases |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000500204 |
Resumo: | ABSTRACT Introduction: In the current standard of care (SoC) RT-PCR method for COVID-19, the patient’s swab was extracted in viral transport media (VTM). For the PanbioTM COVID-19 Ag Rapid Test, the patient swab is flushed out in extraction buffer, of which a small fraction is used for testing, leaving more than half the sample unused. This study was designed to show that RT-PCR results from the residual sample of the PanbioTM COVID-19 Ag Rapid Test (called Novel RT-PCR) are not worse than the SoC RT-PCR result. Methods: The study was performed using (1) dilution series of five patient samples, and (2) 413 patient samples comparing SOC versus Novel RT-PCR results. Results: For the dilution series samples, all tested positive by both methods. The bias between Ct values of Novel RT-PCR and SoC RT-PCR did not exceed 3.00 Ct using primers N1 and N2. A total of 413 COVID symptomatic patients seeking COVID testing were tested, of which 89 patients tested positive and 324 tested negative with SoC RT-PCR. In 324 patients who tested negative with SoC RT-PCR, 323 tested negative with Novel RT-PCR, and one (1) tested positive. Out of 89 who tested positive with SoC RT-PCR, 80 tested positive with the Novel RT-PCR, and nine patients showed a negative test result. The Overall Percent Agreement for the 413 valid patient sample pairs was 97.5 [95% CI 97 to 98]. Conclusion: The study demonstrated that the performance of the Novel RT-PCR method is acceptable compared to the SoC RT-PCR method and can be a useful tool to perform RTPCR without the need for new swab collections. |
id |
BSID-1_53a3c068b66e2c1dfff05aa0d3586e66 |
---|---|
oai_identifier_str |
oai:scielo:S1413-86702021000500204 |
network_acronym_str |
BSID-1 |
network_name_str |
Brazilian Journal of Infectious Diseases |
repository_id_str |
|
spelling |
Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 testCOVID-19Antigen rapid testRT-PCRABSTRACT Introduction: In the current standard of care (SoC) RT-PCR method for COVID-19, the patient’s swab was extracted in viral transport media (VTM). For the PanbioTM COVID-19 Ag Rapid Test, the patient swab is flushed out in extraction buffer, of which a small fraction is used for testing, leaving more than half the sample unused. This study was designed to show that RT-PCR results from the residual sample of the PanbioTM COVID-19 Ag Rapid Test (called Novel RT-PCR) are not worse than the SoC RT-PCR result. Methods: The study was performed using (1) dilution series of five patient samples, and (2) 413 patient samples comparing SOC versus Novel RT-PCR results. Results: For the dilution series samples, all tested positive by both methods. The bias between Ct values of Novel RT-PCR and SoC RT-PCR did not exceed 3.00 Ct using primers N1 and N2. A total of 413 COVID symptomatic patients seeking COVID testing were tested, of which 89 patients tested positive and 324 tested negative with SoC RT-PCR. In 324 patients who tested negative with SoC RT-PCR, 323 tested negative with Novel RT-PCR, and one (1) tested positive. Out of 89 who tested positive with SoC RT-PCR, 80 tested positive with the Novel RT-PCR, and nine patients showed a negative test result. The Overall Percent Agreement for the 413 valid patient sample pairs was 97.5 [95% CI 97 to 98]. Conclusion: The study demonstrated that the performance of the Novel RT-PCR method is acceptable compared to the SoC RT-PCR method and can be a useful tool to perform RTPCR without the need for new swab collections.Brazilian Society of Infectious Diseases2021-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000500204Brazilian Journal of Infectious Diseases v.25 n.5 2021reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1016/j.bjid.2021.101630info:eu-repo/semantics/openAccessCastineiras,Terezinha Marta Pereira PintoNascimento,Érica Ramos dos SantosFaffe,Débora SouzaGalliez,Rafael MelloMariani,DianaLeitão,Isabela de CarvalhoMelo,Mayla Gabryele Miranda deFerreira,Orlando CostaTanuri,Amilcareng2021-11-25T00:00:00Zoai:scielo:S1413-86702021000500204Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2021-11-25T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false |
dc.title.none.fl_str_mv |
Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test |
title |
Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test |
spellingShingle |
Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test Castineiras,Terezinha Marta Pereira Pinto COVID-19 Antigen rapid test RT-PCR |
title_short |
Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test |
title_full |
Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test |
title_fullStr |
Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test |
title_full_unstemmed |
Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test |
title_sort |
Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test |
author |
Castineiras,Terezinha Marta Pereira Pinto |
author_facet |
Castineiras,Terezinha Marta Pereira Pinto Nascimento,Érica Ramos dos Santos Faffe,Débora Souza Galliez,Rafael Mello Mariani,Diana Leitão,Isabela de Carvalho Melo,Mayla Gabryele Miranda de Ferreira,Orlando Costa Tanuri,Amilcar |
author_role |
author |
author2 |
Nascimento,Érica Ramos dos Santos Faffe,Débora Souza Galliez,Rafael Mello Mariani,Diana Leitão,Isabela de Carvalho Melo,Mayla Gabryele Miranda de Ferreira,Orlando Costa Tanuri,Amilcar |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Castineiras,Terezinha Marta Pereira Pinto Nascimento,Érica Ramos dos Santos Faffe,Débora Souza Galliez,Rafael Mello Mariani,Diana Leitão,Isabela de Carvalho Melo,Mayla Gabryele Miranda de Ferreira,Orlando Costa Tanuri,Amilcar |
dc.subject.por.fl_str_mv |
COVID-19 Antigen rapid test RT-PCR |
topic |
COVID-19 Antigen rapid test RT-PCR |
description |
ABSTRACT Introduction: In the current standard of care (SoC) RT-PCR method for COVID-19, the patient’s swab was extracted in viral transport media (VTM). For the PanbioTM COVID-19 Ag Rapid Test, the patient swab is flushed out in extraction buffer, of which a small fraction is used for testing, leaving more than half the sample unused. This study was designed to show that RT-PCR results from the residual sample of the PanbioTM COVID-19 Ag Rapid Test (called Novel RT-PCR) are not worse than the SoC RT-PCR result. Methods: The study was performed using (1) dilution series of five patient samples, and (2) 413 patient samples comparing SOC versus Novel RT-PCR results. Results: For the dilution series samples, all tested positive by both methods. The bias between Ct values of Novel RT-PCR and SoC RT-PCR did not exceed 3.00 Ct using primers N1 and N2. A total of 413 COVID symptomatic patients seeking COVID testing were tested, of which 89 patients tested positive and 324 tested negative with SoC RT-PCR. In 324 patients who tested negative with SoC RT-PCR, 323 tested negative with Novel RT-PCR, and one (1) tested positive. Out of 89 who tested positive with SoC RT-PCR, 80 tested positive with the Novel RT-PCR, and nine patients showed a negative test result. The Overall Percent Agreement for the 413 valid patient sample pairs was 97.5 [95% CI 97 to 98]. Conclusion: The study demonstrated that the performance of the Novel RT-PCR method is acceptable compared to the SoC RT-PCR method and can be a useful tool to perform RTPCR without the need for new swab collections. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000500204 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000500204 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1016/j.bjid.2021.101630 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Brazilian Society of Infectious Diseases |
publisher.none.fl_str_mv |
Brazilian Society of Infectious Diseases |
dc.source.none.fl_str_mv |
Brazilian Journal of Infectious Diseases v.25 n.5 2021 reponame:Brazilian Journal of Infectious Diseases instname:Brazilian Society of Infectious Diseases (BSID) instacron:BSID |
instname_str |
Brazilian Society of Infectious Diseases (BSID) |
instacron_str |
BSID |
institution |
BSID |
reponame_str |
Brazilian Journal of Infectious Diseases |
collection |
Brazilian Journal of Infectious Diseases |
repository.name.fl_str_mv |
Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID) |
repository.mail.fl_str_mv |
bjid@bjid.org.br||lgoldani@ufrgs.br |
_version_ |
1754209245389127680 |